Document ID: chunk:federal_register_of_legislation:F2024C01228:reg:112
Version: federal_register_of_legislation:F2024C01228
Segment Type: reg
Provision Reference: reg 112
Character Range: 68745–69941

112   Vaccine                                                                                                                                                                                                                                                                                PneumoVax 23       Injection (0.5mL)                                                                 Polysaccharides of Streptococcus pneumoniae serotypes 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F — 25 µg of each serotype                                                                                                                                                                              1 to 3 doses
      Pneumococcal (polysaccharide, 23‑valent)

      Circumstances
      Vaccine may be provided:
       (a) in the circumstances set out in subsection 7(2); or
       (b) to a person who is undergoing treatment, or will commence treatment, with Empavali (pegcetacoplan) for the treatment of adults with paroxysmal nocturnal haemoglobinuria who have an inadequate clinical response or are intolerant to treatment with eculizumab or ravulizumab.